A subsidiary of Indian generic drug-maker Ranbaxy Laboratories has pleaded guilty to federal charges of selling adulterated drugs with intent to defraud and agreed to pay $500 million to resolve false claim allegations. The US …
While Big Pharma and other US companies are fuming against Indian generic drugs and the pharma industry, former president Bill Clinton lauded Indian drug companies like Ranbaxy and Cipla for their huge contribution in the battle …
To exclusively market the generic version of Pfizer Inc.'s anti-depression drug Pristiq in the US, the US arm of Indian drug major Ranbaxy Laboratories has entered into an in-licensing agreement with Alembic Pharmaceuticals …
A new anti-malarial drug developed by Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organization, has received pre-qualification from the World Health Organisation (WHO). Drug firm Cipla …
In a path-breaking move that will help bring HIV medicine to the masses, drug giant Gilead Sciences signed deals with three Indian firms, including Ranbaxy Laboratories to collaborate on providing low-cost generic versions of its …
Leading Indian drug manufacturer Ranbaxy Laboratories has boosted its presence in the emerging market of Africa, introducing its new malaria-fighting drug Synriam and setting up manufacturing facilities in Morocco, Nigeria and …
Ranbaxy laboratories today launched a new antimalarial drug, Synriam to treat malaria caused by plasmodium falciparum parasite. The drug will treat uncomplicated malaria. The research, which took place for nine years, was partly …
